Literature DB >> 12391164

Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.

Jennifer J Westendorf1, S Kaleem Zaidi, Jonathan E Cascino, Rachel Kahler, André J van Wijnen, Jane B Lian, Minoru Yoshida, Gary S Stein, Xiaodong Li.   

Abstract

Runx2 (Cbfa1, AML-3) is multifunctional transcription factor that is essential for osteoblast development. Runx2 binds specific DNA sequences and interacts with transcriptional coactivators and corepressors to either activate or repress transcription of tissue-specific genes. In this study, the p21(CIP/WAF1) promoter was identified as a repressible target of Runx2. A carboxy-terminal repression domain distinct from the well-characterized TLE/Groucho-binding domain contributed to Runx2-mediated p21 repression. This carboxy-terminal domain was sufficient to repress a heterologous GAL reporter. The repressive activity of this domain was sensitive to the histone deacetylase inhibitor trichostatin A but not to trapoxin B. HDAC6, which is insensitive to trapoxin B, specifically interacted with the carboxy terminus of Runx2. The HDAC6 interaction domain of Runx2 was mapped to a region overlapping the nuclear matrix-targeting signal. The Runx2 carboxy terminus was necessary for recruitment of HDAC6 from the cytoplasm to chromatin. HDAC6 also colocalized and coimmunoprecipitated with the nuclear matrix-associated protein Runx2 in osteoblasts. Finally, we show that HDAC6 is expressed in differentiating osteoblasts and that the Runx2 carboxy terminus is necessary for maximal repression of the p21 promoter in preosteoblasts. These data identify Runx2 as the first transcription factor to interact with HDAC6 and suggest that HDAC6 may bind to Runx2 in differentiating osteoblasts to regulate tissue-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391164      PMCID: PMC134736          DOI: 10.1128/MCB.22.22.7982-7992.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes.

Authors:  E Smith; R A Redman; C R Logg; G A Coetzee; N Kasahara; B Frenkel
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

2.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

3.  Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm.

Authors:  A Verdel; S Curtet; M P Brocard; S Rousseaux; C Lemercier; M Yoshida; S Khochbin
Journal:  Curr Biol       Date:  2000-06-15       Impact factor: 10.834

4.  Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2.

Authors:  L Tang; B Guo; A Javed; J Y Choi; S Hiebert; J B Lian; A J van Wijnen; J L Stein; G S Stein; G W Zhou
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

Authors:  V M Richon; T W Sandhoff; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 6.  Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.

Authors:  B Lutterbach; S W Hiebert
Journal:  Gene       Date:  2000-03-21       Impact factor: 3.688

Review 7.  Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.

Authors:  Y Sowa; T Orita; S Hiranabe-Minamikawa; K Nakano; T Mizuno; H Nomura; T Sakai
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

8.  Cbfa1 is a positive regulatory factor in chondrocyte maturation.

Authors:  H Enomoto; M Enomoto-Iwamoto; M Iwamoto; S Nomura; M Himeno; Y Kitamura; T Kishimoto; T Komori
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

9.  Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.

Authors:  C M Grozinger; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

10.  Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription.

Authors:  A Javed; B Guo; S Hiebert; J Y Choi; J Green; S C Zhao; M A Osborne; S Stifani; J L Stein; J B Lian; A J van Wijnen; G S Stein
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

View more
  123 in total

Review 1.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  ChIP Display: novel method for identification of genomic targets of transcription factors.

Authors:  Artem Barski; Baruch Frenkel
Journal:  Nucleic Acids Res       Date:  2004-07-13       Impact factor: 16.971

3.  A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.

Authors:  Nate P Hoverter; Ju-Hui Ting; Suman Sundaresh; Pierre Baldi; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

4.  Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.

Authors:  Yuanjing Liu; Lirong Peng; Edward Seto; Suming Huang; Yi Qiu
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

Review 5.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

6.  Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.

Authors:  Ya-Huei Kuo; Sayyed K Zaidi; Svetlana Gornostaeva; Toshihisa Komori; Gary S Stein; Lucio H Castilla
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

Review 7.  Transcription-factor-mediated epigenetic control of cell fate and lineage commitment.

Authors:  Gary S Stein; Sayyed K Zaidi; Janet L Stein; Jane B Lian; Andre J van Wijnen; Martin Montecino; Daniel W Young; Amjad Javed; Jitesh Pratap; Je-Yong Choi; Syed A Ali; Sandhya Pande; Mohammad Q Hassan
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

8.  Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.

Authors:  Eric D Jensen; Tania M Schroeder; Jaclyn Bailey; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

9.  A positive role of microRNA-15b on regulation of osteoblast differentiation.

Authors:  S Vimalraj; Nicola C Partridge; N Selvamurugan
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

10.  FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.

Authors:  Ok-Jin Park; Hyun-Jung Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.